Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00243867
Status:
COMPLETED
Last Update Posted:
2018-01-26
First Post:
2005-10-21
Brief Title:
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
Sponsor:
American Regent Inc
Organization:
American Regent Inc
Organization Data
Organization:
American Regent Inc
Class:
INDUSTRY
Study ID:
P01-04-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
American Regent Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None